Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP888410.RA7mHjDuWE5chFn7RP9-kaZiAoDXUkBRO-s3sc6mQBXR4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP888410.RA7mHjDuWE5chFn7RP9-kaZiAoDXUkBRO-s3sc6mQBXR4130_assertion type Assertion NP888410.RA7mHjDuWE5chFn7RP9-kaZiAoDXUkBRO-s3sc6mQBXR4130_head.
- NP888410.RA7mHjDuWE5chFn7RP9-kaZiAoDXUkBRO-s3sc6mQBXR4130_assertion description "[We describe the development of the first ELISA for myostatin immunoreactivity and its validation during recompensating therapy for CHF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP888410.RA7mHjDuWE5chFn7RP9-kaZiAoDXUkBRO-s3sc6mQBXR4130_provenance.
- NP888410.RA7mHjDuWE5chFn7RP9-kaZiAoDXUkBRO-s3sc6mQBXR4130_assertion evidence source_evidence_literature NP888410.RA7mHjDuWE5chFn7RP9-kaZiAoDXUkBRO-s3sc6mQBXR4130_provenance.
- NP888410.RA7mHjDuWE5chFn7RP9-kaZiAoDXUkBRO-s3sc6mQBXR4130_assertion SIO_000772 22561185 NP888410.RA7mHjDuWE5chFn7RP9-kaZiAoDXUkBRO-s3sc6mQBXR4130_provenance.
- NP888410.RA7mHjDuWE5chFn7RP9-kaZiAoDXUkBRO-s3sc6mQBXR4130_assertion wasDerivedFrom befree-20140225 NP888410.RA7mHjDuWE5chFn7RP9-kaZiAoDXUkBRO-s3sc6mQBXR4130_provenance.
- NP888410.RA7mHjDuWE5chFn7RP9-kaZiAoDXUkBRO-s3sc6mQBXR4130_assertion wasGeneratedBy ECO_0000203 NP888410.RA7mHjDuWE5chFn7RP9-kaZiAoDXUkBRO-s3sc6mQBXR4130_provenance.